MTND5 can catalyze the synthesis of NADH-ubiquinone oxidoreductase complex I at an early stage [82], and MTND5 deletion or mutation is associated with various mitochondrial diseases [83–86]. This evidence concerns the gene MT-ND5 and mitochondrial disease.